These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29742588)

  • 1. Derivation and Validation of a Biomarker-Based Clinical Algorithm to Rule Out Sepsis From Noninfectious Systemic Inflammatory Response Syndrome at Emergency Department Admission: A Multicenter Prospective Study.
    Mearelli F; Fiotti N; Giansante C; Casarsa C; Orso D; De Helmersen M; Altamura N; Ruscio M; Castello LM; Colonetti E; Marino R; Barbati G; Bregnocchi A; Ronco C; Lupia E; Montrucchio G; Muiesan ML; Di Somma S; Avanzi GC; Biolo G
    Crit Care Med; 2018 Sep; 46(9):1421-1429. PubMed ID: 29742588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture-negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study.
    Anand D; Das S; Bhargava S; Srivastava LM; Garg A; Tyagi N; Taneja S; Ray S
    J Crit Care; 2015 Feb; 30(1):218.e7-12. PubMed ID: 25263339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic ability of procalcitonin and interleukin-6 to differentiate infectious from noninfectious systemic inflammatory response syndrome and to predict mortality.
    Mat-Nor MB; Md Ralib A; Abdulah NZ; Pickering JW
    J Crit Care; 2016 Jun; 33():245-51. PubMed ID: 26851139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock.
    Clec'h C; Fosse JP; Karoubi P; Vincent F; Chouahi I; Hamza L; Cupa M; Cohen Y
    Crit Care Med; 2006 Jan; 34(1):102-7. PubMed ID: 16374163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis.
    Shapiro NI; Trzeciak S; Hollander JE; Birkhahn R; Otero R; Osborn TM; Moretti E; Nguyen HB; Gunnerson KJ; Milzman D; Gaieski DF; Goyal M; Cairns CB; Ngo L; Rivers EP
    Crit Care Med; 2009 Jan; 37(1):96-104. PubMed ID: 19050610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in Histidine-Rich Glycoprotein as a Novel Biomarker to Predict Sepsis Among Systemic Inflammatory Response Syndrome.
    Kuroda K; Wake H; Mori S; Hinotsu S; Nishibori M; Morimatsu H
    Crit Care Med; 2018 Apr; 46(4):570-576. PubMed ID: 29303798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-Binding Protein Measurement Improves the Prediction of Severe Infection With Organ Dysfunction in the Emergency Department.
    Linder A; Arnold R; Boyd JH; Zindovic M; Zindovic I; Lange A; Paulsson M; Nyberg P; Russell JA; Pritchard D; Christensson B; Åkesson P
    Crit Care Med; 2015 Nov; 43(11):2378-86. PubMed ID: 26468696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of soluble thrombomodulin in the risk stratification and prognosis evaluation of septic patients in the emergency department.
    Yin Q; Liu B; Chen Y; Zhao Y; Li C
    Thromb Res; 2013 Oct; 132(4):471-6. PubMed ID: 24035044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of procalcitonin, interleukin-6 and C-reactive protein in the differential diagnosis of patients with sepsis syndrome in intensive care units].
    Průcha M; Herold I; Zazula R; Dubská L; Kavka B; Dostál M
    Vnitr Lek; 2003 Jul; 49(7):541-7. PubMed ID: 12931436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a Combination Biomarker Algorithm To Identify Medical Intensive Care Unit Patients with Suspected Sepsis at Very Low Likelihood of Bacterial Infection.
    Han JH; Nachamkin I; Coffin SE; Gerber JS; Fuchs B; Garrigan C; Han X; Bilker WB; Wise J; Tolomeo P; Lautenbach E;
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6494-500. PubMed ID: 26239984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presepsin is an early monitoring biomarker for predicting clinical outcome in patients with sepsis.
    Ali FT; Ali MA; Elnakeeb MM; Bendary HN
    Clin Chim Acta; 2016 Sep; 460():93-101. PubMed ID: 27353646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Algorithm for Systemic Inflammatory Response Syndrome Criteria-Based Prediction of Sepsis in a Polytrauma Cohort.
    Lindner HA; Balaban Ü; Sturm T; Weiß C; Thiel M; Schneider-Lindner V
    Crit Care Med; 2016 Dec; 44(12):2199-2207. PubMed ID: 27441906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6.
    Selberg O; Hecker H; Martin M; Klos A; Bautsch W; Köhl J
    Crit Care Med; 2000 Aug; 28(8):2793-8. PubMed ID: 10966252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock.
    Brunkhorst FM; Wegscheider K; Forycki ZF; Brunkhorst R
    Intensive Care Med; 2000 Mar; 26 Suppl 2():S148-52. PubMed ID: 18470710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble urokinase-type plasminogen activator receptor in patients with suspected infection in the emergency room: a prospective cohort study.
    Uusitalo-Seppälä R; Huttunen R; Tarkka M; Aittoniemi J; Koskinen P; Leino A; Vahlberg T; Rintala EM
    J Intern Med; 2012 Sep; 272(3):247-56. PubMed ID: 22755554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department].
    Zhao Y; Li C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):153-8. PubMed ID: 24598287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.
    Prasad PA; Fang MC; Abe-Jones Y; Calfee CS; Matthay MA; Kangelaris KN
    Crit Care Med; 2020 Feb; 48(2):200-209. PubMed ID: 31939788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of presepsin in diagnosis and risk stratification for the emergency patients with sepsis.
    Lu B; Zhang Y; Li C; Liu C; Yao Y; Su M; Shou S
    Am J Emerg Med; 2018 Aug; 36(8):1341-1345. PubMed ID: 29276032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Two-Biomarker Model Predicts Mortality in the Critically Ill with Sepsis.
    Mikacenic C; Price BL; Harju-Baker S; O'Mahony DS; Robinson-Cohen C; Radella F; Hahn WO; Katz R; Christiani DC; Himmelfarb J; Liles WC; Wurfel MM
    Am J Respir Crit Care Med; 2017 Oct; 196(8):1004-1011. PubMed ID: 28418697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction.
    Castelli GP; Pognani C; Meisner M; Stuani A; Bellomi D; Sgarbi L
    Crit Care; 2004 Aug; 8(4):R234-42. PubMed ID: 15312223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.